Celldex Therapeutics, Inc. reports

Company location: Hampton, NJ
Fiscal year end: 31 December

Celldex Therapeutics, Inc. has filed 1,268 SEC EDGAR filings since 06 Apr 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 776-800 of 814 matching filings.

Per page

25

Current page

32

8-K File 000-15006

CELLDEX THERAPEUTICS, INC. 8-K

Filing date: 02 Nov 2010
Reporting date: 02 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 22 Sep 2010
Reporting date: 22 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 17 Sep 2010
Reporting date: 16 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 16 Sep 2010
Reporting date: 16 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-15006

8-K

Filing date: 16 Sep 2010
Reporting date: 15 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 14 Sep 2010
Reporting date: 13 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 13 Sep 2010
Reporting date: 13 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 13 Sep 2010
Reporting date: 10 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 13 Sep 2010
Reporting date: 10 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 13 Sep 2010
Reporting date: 09 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 09 Sep 2010
Reporting date: 09 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 09 Sep 2010
Reporting date: 08 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-15006

8-K

Filing date: 07 Sep 2010
Reporting date: 01 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-15006

10-Q

Filing date: 05 Aug 2010
Reporting date: 30 Jun 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 000-15006

DEF 14A

Filing date: 04 Aug 2010
Reporting date: 15 Sep 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-15006

CELLDEX THERAPEUTICS, INC. 8-K

Filing date: 04 Aug 2010
Reporting date: 04 Aug 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-15006

10-Q

Filing date: 06 May 2010
Reporting date: 31 Mar 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-15006

CELLDEX THERAPEUTICS, INC. 8-K

Filing date: 04 May 2010
Reporting date: 04 May 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-165899

EFFECT filing

Filing date: 22 Apr 2010
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .